Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer
about
Improving tumour heterogeneity MRI assessment with histograms.Correlation of Hsp70 Serum Levels with Gross Tumor Volume and Composition of Lymphocyte Subpopulations in Patients with Squamous Cell and Adeno Non-Small Cell Lung Cancer.Role of 3T multiparametric-MRI with BOLD hypoxia imaging for diagnosis and post therapy response evaluation of postoperative recurrent cervical cancers.Onset time of tumor repopulation for cervical cancer: first evidence from clinical data.Sequential magnetic resonance imaging of cervical cancer: the predictive value of absolute tumor volume and regression ratio measured before, during, and after radiation therapy.Imaging across the life span: innovations in imaging and therapy for gynecologic cancer.Validation of optimal DCE-MRI perfusion threshold to classify at-risk tumor imaging voxels in heterogeneous cervical cancer for outcome predictionCharacterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model.Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies.Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging.Time-window of early detection of response to concurrent chemoradiation in cervical cancer by using diffusion-weighted MR imaging: a pilot study.Changes in Tumor Biology During Chemoradiation of Cervix Cancer Assessed by Multiparametric MRI and Hypoxia PET.Pretreatment Dynamic Contrast-Enhanced MRI Improves Prediction of Early Distant Metastases in Patients With Nasopharyngeal Carcinoma.Characterizing at-Risk Voxels by Using Perfusion Magnetic Resonance Imaging for Cervical Cancer during Radiotherapy.Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapyDynamic Contrast-enhanced MR Imaging in Renal Cell Carcinoma: Reproducibility of Histogram Analysis on Pharmacokinetic Parameters.Can Dynamic Contrast-Enhanced MRI (DCE-MRI) and Diffusion-Weighted MRI (DW-MRI) Evaluate Inflammation Disease: A Preliminary Study of Crohn's DiseaseThe Microenvironment of Cervical Carcinoma Xenografts: Associations with Lymph Node Metastasis and Its Assessment by DCE-MRI.Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review.Functional imaging for assessing tumor response in cancer of the cervix.Dynamic contrast-enhanced MRI of gastric cancer: Correlation of the perfusion parameters with pathological prognostic factors.Models and methods for analyzing DCE-MRI: a review.Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.Hypoxia in cervical cancer: from biology to imaging.The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant Ktrans in cervical cancer is explained by plasma flow rather than vessel permeability.Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer.A radiobiological model of radiotherapy response and its correlation with prognostic imaging variables.Blind estimation of the arterial input function in dynamic contrast-enhanced MRI using purity maximization.Dynamic contrast-enhanced-MRI of tumor hypoxia.Predictive and prognostic value of intravoxel incoherent motion (IVIM) MR imaging in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.The value of advanced MRI techniques in the assessment of cervical cancer: a review.Dynamic contrast enhanced MRI detects changes in vascular transport rate constants following treatment with thermally-sensitive liposomal doxorubicin.Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy.What's New in Imaging for Gynecologic Cancer?A mathematical model of tumor volume changes during radiotherapy.Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.Dynamic contrast-enhanced 3-T MR imaging in cervical cancer before and after concurrent chemoradiotherapy.
P2860
Q27693208-C20F4301-028C-4753-8155-4F46E56A4525Q30315956-00FFAA34-D08C-459B-BAD6-1D2E8FFC86FFQ31074898-6AB4A966-F99F-47C5-9A2B-CB145F10366AQ34183486-DBA75C41-FF1A-4727-AC9E-A66D0C5E355FQ34217653-22CF642C-4A43-493F-9785-6D62FD300EEEQ35057017-295417B6-8A84-4152-B35B-2416CF4E9436Q35142265-17BE49AA-B131-4091-9083-30929081E714Q35216099-00DC7983-42C3-4A2F-B23E-448F60F09523Q35609995-3ABE1117-D31B-435C-8166-6127D9C2861BQ35918597-F9EE0371-0201-447E-9451-EDE9B3C29EEFQ36023233-7F34AF35-F2A8-4006-8CFE-E1F8E20FE617Q36379633-2D49470C-3C9B-453F-8B83-9B0C67A8E248Q36580841-859661AD-306D-4F42-B8C5-79D102175056Q36800482-FFDAD58C-14D4-44F7-AA34-2B9E8039D8CBQ37042355-46AB18B1-2B22-439C-87C2-A763F0589CDCQ37067622-32FE48D6-F262-4140-A605-A8DB572E8A41Q37206657-0FA06043-3324-469D-9306-265528CC57E9Q37236037-808B9151-8EFB-4773-B8F6-EFB3B64DDF5AQ37871859-2CB4FA1E-C9C4-49E6-A465-DCF7DD20DE9AQ37905821-3F1543A6-AD14-48B9-B24E-AFFEBCB8BC50Q38232035-570677E0-155D-43FC-8253-FD11A673B706Q38282639-F34A52FA-15B6-413B-B6A5-CB2A7D3FDAF7Q38606106-6295DB9F-8A6D-4B25-AD3F-889501D22429Q38643119-E7D5A435-81C0-4B10-914C-D9B5F7BC47CBQ38816759-8FD1AFA2-7F25-44BD-8AEE-FE80BF80DA96Q38817570-C677FF67-F4FC-4304-B91E-8D97F43D5539Q38989862-00908A99-9481-453A-9D45-4A61CFEAD4C7Q39387171-00FBD660-F084-46B1-88FD-6FF568146A25Q39526998-4CC9FD39-291E-4143-AE43-5E820B1E4847Q41046497-FEC2A66B-942A-4AD2-B7A4-DBD71D84F077Q42367717-B67E58B9-239F-4121-829B-00B6962894A4Q46626263-5AD725D2-6CD5-47E2-BD36-A5D444C7FD70Q47769079-6DDB0DB6-2902-43F6-87B2-B1A46BE8A7D9Q50145613-4E7154EC-8FF0-4C32-A3B8-8C141A23F27CQ51142106-7B50E044-D6B5-437D-8874-BC68D72B3F63Q53096620-618D128C-52D3-44BF-B9CD-92BA455E2FC3Q53373746-FCE9DDA4-2E21-498E-9C03-A5A42AD387D3
P2860
Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Predicting control of primary ...... rly therapy in cervical cancer
@en
Predicting control of primary ...... ly therapy in cervical cancer.
@nl
type
label
Predicting control of primary ...... rly therapy in cervical cancer
@en
Predicting control of primary ...... ly therapy in cervical cancer.
@nl
prefLabel
Predicting control of primary ...... rly therapy in cervical cancer
@en
Predicting control of primary ...... ly therapy in cervical cancer.
@nl
P2093
P2860
P1476
Predicting control of primary ...... rly therapy in cervical cancer
@en
P2093
David Jarjoura
Hualin Zhang
Jeffrey Fowler
Jian Z Wang
John C Grecula
Joseph F Montebello
Michael V Knopp
Nina A Mayr
Simon S Lo
P2860
P304
P356
10.1097/RLI.0B013E3181A64CE9
P577
2009-06-01T00:00:00Z